Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study
- PMID: 20946997
- DOI: 10.1016/j.jacc.2010.06.030
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study
Abstract
Objectives: The purpose of this study was to determine net reclassification improvement (NRI) and improved risk prediction based on coronary artery calcification (CAC) scoring in comparison with traditional risk factors.
Background: CAC as a sign of subclinical coronary atherosclerosis can noninvasively be detected by CT and has been suggested to predict coronary events.
Methods: In 4,129 subjects from the HNR (Heinz Nixdorf Recall) study (age 45 to 75 years, 53% female) without overt coronary artery disease at baseline, traditional risk factors and CAC scores were measured. Their risk was categorized into low, intermediate, and high according to the Framingham Risk Score (FRS) and National Cholesterol Education Panel Adult Treatment Panel (ATP) III guidelines, and the reclassification rate based on CAC results was calculated.
Results: After 5 years of follow-up, 93 coronary deaths and nonfatal myocardial infarctions occurred (cumulative risk 2.3%; 95% confidence interval: 1.8% to 2.8%). Reclassifying intermediate (defined as 10% to 20% and 6% to 20%) risk subjects with CAC <100 to the low-risk category and with CAC ≥400 to the high-risk category yielded an NRI of 21.7% (p = 0.0002) and 30.6% (p < 0.0001) for the FRS, respectively. Integrated discrimination improvement using FRS variables and CAC was 1.52% (p < 0.0001). Adding CAC scores to the FRS and National Cholesterol Education Panel ATP III categories improved the area under the curve from 0.681 to 0.749 (p < 0.003) and from 0.653 to 0.755 (p = 0.0001), respectively.
Conclusions: CAC scoring results in a high reclassification rate in the intermediate-risk cohort, demonstrating the benefit of imaging of subclinical coronary atherosclerosis. Our study supports its application, especially in carefully selected individuals with intermediate risk.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Coronary artery calcification, an improvement in risk classification: need for reappraisal?J Am Coll Cardiol. 2010 Oct 19;56(17):1415-7. doi: 10.1016/j.jacc.2010.06.027. J Am Coll Cardiol. 2010. PMID: 20946999 No abstract available.
-
Is reclassification of intermediate-risk subjects by coronary artery calcium scoring clinically useful?J Am Coll Cardiol. 2011 Aug 30;58(10):1081; author reply 1081-3. doi: 10.1016/j.jacc.2010.11.085. J Am Coll Cardiol. 2011. PMID: 21867847 No abstract available.
Similar articles
-
Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality.J Am Coll Cardiol. 2011 Mar 29;57(13):1455-64. doi: 10.1016/j.jacc.2010.10.043. J Am Coll Cardiol. 2011. PMID: 21435514
-
Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation.Atherosclerosis. 2008 Apr;197(2):662-72. doi: 10.1016/j.atherosclerosis.2007.02.031. Epub 2007 Mar 26. Atherosclerosis. 2008. PMID: 17386928
-
Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.Eur J Prev Cardiol. 2014 Sep;21(9):1171-9. doi: 10.1177/2047487313490256. Epub 2013 May 14. Eur J Prev Cardiol. 2014. PMID: 23674833
-
Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score.Int J Cardiol. 2006 Jun 16;110(2):129-36. doi: 10.1016/j.ijcard.2005.09.009. Epub 2005 Nov 21. Int J Cardiol. 2006. PMID: 16303191 Review.
-
Added value of CAC in risk stratification for cardiovascular events: a systematic review.Eur J Clin Invest. 2012 Jan;42(1):110-6. doi: 10.1111/j.1365-2362.2011.02555.x. Epub 2011 Jun 6. Eur J Clin Invest. 2012. PMID: 21644944 Review.
Cited by
-
The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.Clin Cardiol. 2022 Nov;45(11):1107-1113. doi: 10.1002/clc.23918. Epub 2022 Sep 10. Clin Cardiol. 2022. PMID: 36086949 Free PMC article. Review.
-
Coronary Artery Calcification Score as A Predictor of All-Cause Mortality and Cardiovascular Outcome in Peritoneal Dialysis Patients.Perit Dial Int. 2016 Mar-Apr;36(2):163-70. doi: 10.3747/pdi.2014.00124. Epub 2015 Jul 29. Perit Dial Int. 2016. PMID: 26224787 Free PMC article.
-
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12. Circulation. 2013. PMID: 23239837 Free PMC article. Review. No abstract available.
-
Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study.Diabetol Metab Syndr. 2015 Jun 28;7:58. doi: 10.1186/s13098-015-0055-y. eCollection 2015. Diabetol Metab Syndr. 2015. PMID: 26146522 Free PMC article.
-
Association between abdominal aortic plaque and coronary artery disease.Clin Interv Aging. 2016 May 19;11:683-8. doi: 10.2147/CIA.S104425. eCollection 2016. Clin Interv Aging. 2016. PMID: 27279740 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical